Johnson BE - Search Results

1

Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium.

Villaruz LC, Socinski MA, Abberbock S, Berry LD, Johnson BE, Kwiatkowski DJ, Iafrate AJ, Varella-Garcia M, Franklin WA, Camidge DR, Sequist LV, Haura EB, Ladanyi M, Kurland BF, Kugler K, Minna JD, Bunn PA, Kris MG. Villaruz LC, et al. Among authors: johnson be. Cancer. 2015 Feb 1;121(3):448-56. doi: 10.1002/cncr.29042. Epub 2014 Oct 1. Cancer. 2015. PMID: 25273224 Free PMC article.

2

Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation.

Winter SF, Minna JD, Johnson BE, Takahashi T, Gazdar AF, Carbone DP. Winter SF, et al. Among authors: johnson be. Cancer Res. 1992 Aug 1;52(15):4168-74. Cancer Res. 1992. PMID: 1322237

3

myc family DNA amplification in tumors and tumor cell lines from patients with small-cell lung cancer.

Johnson BE, Brennan JF, Ihde DC, Gazdar AF. Johnson BE, et al. J Natl Cancer Inst Monogr. 1992;(13):39-43. J Natl Cancer Inst Monogr. 1992. PMID: 1327035

4

Polymorphic sites within the MCC and APC loci reveal very frequent loss of heterozygosity in human small cell lung cancer.

D'Amico D, Carbone DP, Johnson BE, Meltzer SJ, Minna JD. D'Amico D, et al. Among authors: johnson be. Cancer Res. 1992 Apr 1;52(7):1996-9. Cancer Res. 1992. PMID: 1348017

5

Best papers on lung cancer.

Johnson BE. Johnson BE. Cancer Invest. 1992;10(5):491-2. doi: 10.3109/07357909209024809. Cancer Invest. 1992. PMID: 1393696 No abstract available.

6

myc family DNA amplification in 107 tumors and tumor cell lines from patients with small cell lung cancer treated with different combination chemotherapy regimens.

Brennan J, O'Connor T, Makuch RW, Simmons AM, Russell E, Linnoila RI, Phelps RM, Gazdar AF, Ihde DC, Johnson BE. Brennan J, et al. Among authors: johnson be. Cancer Res. 1991 Mar 15;51(6):1708-12. Cancer Res. 1991. PMID: 1847842

7

Correlation of in vitro drug-sensitivity testing results with response to chemotherapy and survival in extensive-stage small cell lung cancer: a prospective clinical trial.

Gazdar AF, Steinberg SM, Russell EK, Linnoila RI, Oie HK, Ghosh BC, Cotelingam JD, Johnson BE, Minna JD, Ihde DC. Gazdar AF, et al. Among authors: johnson be. J Natl Cancer Inst. 1990 Jan 17;82(2):117-24. doi: 10.1093/jnci/82.2.117. J Natl Cancer Inst. 1990. PMID: 2152944 Clinical Trial.

8

Ten-year survival of patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation.

Johnson BE, Grayson J, Makuch RW, Linnoila RI, Anderson MJ, Cohen MH, Glatstein E, Minna JD, Ihde DC. Johnson BE, et al. J Clin Oncol. 1990 Mar;8(3):396-401. doi: 10.1200/JCO.1990.8.3.396. J Clin Oncol. 1990. PMID: 2155310

9

Chemosensitivity testing of human lung cancer cell lines using the MTT assay.

Carmichael J, Mitchell JB, DeGraff WG, Gamson J, Gazdar AF, Johnson BE, Glatstein E, Minna JD. Carmichael J, et al. Among authors: johnson be. Br J Cancer. 1988 Jun;57(6):540-7. doi: 10.1038/bjc.1988.125. Br J Cancer. 1988. PMID: 2841961 Free PMC article.

10

Restriction fragment length polymorphism studies show consistent loss of chromosome 3p alleles in small cell lung cancer patients' tumors.

Johnson BE, Sakaguchi AY, Gazdar AF, Minna JD, Burch D, Marshall A, Naylor SL. Johnson BE, et al. J Clin Invest. 1988 Aug;82(2):502-7. doi: 10.1172/JCI113624. J Clin Invest. 1988. PMID: 2900253 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

587 results

Search Page

Filters